The management outcome of heart failure reduced ejection fraction with or without angiotensin receptor neprilysin inhibitor in Kelantan

被引：0
|
作者：
Wu, J. T. [1 ]
Othman, M. K. [1 ]
Isa, W. Y. H. W. [1 ]
机构：
[1] Hosp Univ Sains Malaysia, Cardiol Unit, Kota Baharu, Kelantan, Malaysia
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2022年 / 369卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
10
引用
收藏
页码：5 / 6
页数：2
相关论文
共 50 条
  • [1] The management outcome of heart failure reduced ejection fraction with or without angiotensin receptor neprilysin inhibitor in Kelantan
    Wu, J. T.
    Othman, M. K.
    Isa, W. Y. H. W.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 369 : 5 - 6
  • [2] FRAILTY AND UPTAKE OF ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR FOR HEART FAILURE WITH REDUCED EJECTION FRACTION
    Ko, Darae
    Lee, Yu-Chien
    Lin, Kueiyu Joshua
    Cheng, Susan
    Patorno, Elisabetta
    Glynn, Robert J.
    Tsacogianis, Theodore
    Kim, Dae Hyun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 521 - 521
  • [3] Angiotensin receptor blocker-neprilysin inhibitor for heart failure with reduced ejection fraction
    Nasrallah, Dima
    Abdelhamid, Alaa
    Tluli, Omar
    Al-Haneedi, Yaman
    Dakik, Habib
    Eid, Ali H.
    PHARMACOLOGICAL RESEARCH, 2024, 204
  • [4] Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction
    Lee, Yu-Chien
    Lin, Joshua K.
    Ko, Darae
    Cheng, Susan
    Patorno, Elisabetta
    Glynn, Robert J.
    Tsacogianis, Theodore
    Kim, Dae Hyun
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 (10) : 3110 - 3121
  • [5] FRAILTY AND UPTAKE OF ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR FOR HEART FAILURE WITH REDUCED EJECTION FRACTION
    Lee, Y.
    Lin, K. J.
    Ko, D.
    Cheng, S.
    Patorno, E.
    Glynn, R. J.
    Tsacogianis, T.
    Kim, D.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S224 - S225
  • [6] Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction
    Malik, Jahanzeb
    Shahid, Abdul Wahab
    Shah, Mohsin
    Rana, Ghazanfar
    Kamal, Ahmed
    Naeem, Hesham
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2021, 11 (05): : 629 - 634
  • [7] Effects of Angiotensin Receptor Neprilysin Inhibitor on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction
    Tabl, Mohamed Abd E.
    Essawy, Tarek Samy
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (04) : S40 - S41
  • [8] Benefits of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure with Reduced Ejection Fraction: A Longitudinal Study
    Jain, Dharmendra
    Pandey, Umesh Kumar
    Tripathi, Suyash
    Kaushley, Abhishek
    Verma, Bhupendra
    Ghosh, Soumik
    Santosh, Krishna Vemuri
    Prajapati, Rajpal
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (04) : EC17 - EC22
  • [9] Positive Recommendation for Angiotensin Receptor-Neprilysin Inhibitor: First Medication Approval for Heart Failure Without Reduced Ejection Fraction
    Howlett, Jonathan G.
    CANADIAN JOURNAL OF CARDIOLOGY, 2021, 37 (04) : 528 - 530
  • [10] The Angiotensin Receptor Neprilysin Inhibitor LCZ696 is Effective Across the Spectrum of Ejection Fraction in Heart Failure With Reduced Ejection Fraction
    Solomon, Scott
    Packer, Milton
    Zile, Michael
    Swedberg, Karl
    Rouleau, Jean
    Letkowitz, Martin
    Shi, Victor
    Desai, Akshay
    Claggett, Brian
    Starling, Randall
    McMurray, John J. V.
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S45 - S46
12345